Titus Kretzschmar
Keine laufenden Positionen mehr
Profil
Titus Kretzschmar held several positions in research and development and technology, including Senior Director at MorphoSys AG, Director at amaxa GmbH, Chief Technical Officer and Head of Future Technologies at Lonza Group AG, and Chief Scientific Officer at Cell Medica Switzerland AG.
Ehemalige bekannte Positionen von Titus Kretzschmar
| Unternehmen | Position | Ende |
|---|---|---|
| MORPHOSYS AG | Technik-/Wissenschafts-/F&E-Leiter | - |
Cell Medica Switzerland AG
 Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Technik-/Wissenschafts-/F&E-Leiter | - |
| LONZA GROUP AG | Technik-/Wissenschafts-/F&E-Leiter | - |
amaxa GmbH
 amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LONZA GROUP AG | Health Technology |
| MORPHOSYS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
amaxa GmbH
amaxa GmbH Miscellaneous Commercial ServicesCommercial Services amaxa GmbH researches gene transfer and gene-based medicines to develop causal therapies for the treatment of severe diseases. It focuses on high-end applications for non-viral delivery of genes and transfer of other charged substrates into cells. The company was founded in 1998 and is headquartered in Cologne, Germany. | Commercial Services |
Cell Medica Switzerland AG
Cell Medica Switzerland AG Pharmaceuticals: MajorHealth Technology Cell Medica Switzerland AG engages in the research, development, production, and distribution of pharmaceutical, biological, medical, and diagnostic products. It provides locally and systemically applied antibody therapeutics under the PENTRA Body platform. The company was founded by Thomas O. Hecht on September 4, 2009 and is headquartered in Schlieren, Switzerland. | Health Technology |
